[{"address1": "5 Science Park", "address2": "395 Winchester Avenue", "city": "New Haven", "state": "CT", "zip": "06511", "country": "United States", "phone": "203 535 1456", "website": "https://www.arvinas.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 3 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. The company's products also consists ARV 393, orally bioavailable PROTAC designed to degrade BCL6, a transcriptional repressor and a key regulator of normal B-cell maturation and differentiation processes which is in Phase 1 first-in-human clinical trial; ARV 102 for the treatment of neurodegenerative diseases, which is in Phase 1 clinical trial; and KRAS G12D program is in preclinical development for pancreatic and colorectal cancers. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.", "fullTimeEmployees": 430, "companyOfficers": [{"maxAge": 1, "name": "Dr. John G. Houston Ph.D.", "age": 64, "title": "Chairperson, CEO & President", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 1124624, "exercisedValue": 0, "unexercisedValue": 847759}, {"maxAge": 1, "name": "Mr. Andrew R. Saik", "age": 55, "title": "CFO & Treasurer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 657193, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela M. Cacace Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 696153, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Randy  Teel Ph.D.", "age": 44, "title": "Chief Business Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 711098, "exercisedValue": 0, "unexercisedValue": 331598}, {"maxAge": 1, "name": "Dr. Noah  Berkowitz M.D., Ph.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 747020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David K. Loomis M.B.A.", "age": 50, "title": "VP & Chief Accounting Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeff  Boyle", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jared M. Freedberg J.D.", "age": 55, "title": "General Counsel & Corporate Secretary", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve  Weiss", "age": 54, "title": "Senior VP & Chief Human Resources Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Sinclair", "title": "Senior Vice President of Corporate Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.02, "open": 11.0, "dayLow": 10.98, "dayHigh": 11.73, "regularMarketPreviousClose": 11.02, "regularMarketOpen": 11.0, "regularMarketDayLow": 10.98, "regularMarketDayHigh": 11.73, "payoutRatio": 0.0, "beta": 2.475, "forwardPE": -2.472103, "volume": 1765509, "regularMarketVolume": 1765509, "averageVolume": 2457436, "averageVolume10days": 3781440, "averageDailyVolume10Day": 3781440, "bid": 11.32, "ask": 11.78, "bidSize": 23, "askSize": 23, "marketCap": 845770688, "fiftyTwoWeekLow": 5.9, "fiftyTwoWeekHigh": 27.0, "allTimeHigh": 108.47, "allTimeLow": 5.9, "priceToSalesTrailing12Months": 2.7081995, "fiftyDayAverage": 9.4168, "twoHundredDayAverage": 9.14335, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -38436132, "profitMargins": -0.18732001, "floatShares": 56092214, "sharesOutstanding": 64224294, "sharesShort": 7764976, "sharesShortPriorMonth": 7986348, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.120900005, "heldPercentInsiders": 0.07881, "heldPercentInstitutions": 0.96033996, "shortRatio": 3.07, "shortPercentOfFloat": 0.123100005, "impliedSharesOutstanding": 73417595, "bookValue": 7.972, "priceToBook": 1.4450577, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -58500000, "trailingEps": -0.81, "forwardEps": -4.66, "enterpriseToRevenue": -0.123, "enterpriseToEbitda": 0.392, "52WeekChange": -0.56182903, "SandP52WeekChange": 0.09209216, "quoteType": "EQUITY", "currentPrice": 11.52, "targetHighPrice": 18.0, "targetLowPrice": 6.0, "targetMeanPrice": 12.3125, "targetMedianPrice": 13.0, "recommendationMean": 2.26316, "recommendationKey": "buy", "numberOfAnalystOpinions": 16, "totalCash": 787600000, "totalCashPerShare": 12.263, "ebitda": -98000000, "totalDebt": 9300000, "quickRatio": 5.62, "currentRatio": 5.703, "totalRevenue": 312300000, "debtToEquity": 1.648, "revenuePerShare": 4.299, "returnOnAssets": -0.06302, "returnOnEquity": -0.1017, "grossProfits": 312300000, "freeCashflow": -154375008, "operatingCashflow": -327500000, "revenueGrowth": -0.591, "grossMargins": 1.0, "ebitdaMargins": -0.31379998, "operatingMargins": -1.05012, "financialCurrency": "USD", "symbol": "ARVN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 4.53721, "regularMarketPrice": 11.52, "longName": "Arvinas, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1538055000000, "postMarketChangePercent": -0.95486635, "postMarketPrice": 11.41, "postMarketChange": -0.11000061, "regularMarketChange": 0.5, "regularMarketDayRange": "10.98 - 11.73", "marketState": "CLOSED", "shortName": "Arvinas, Inc.", "corporateActions": [], "postMarketTime": 1763769905, "regularMarketTime": 1763758802, "exchange": "NMS", "messageBoardId": "finmb_243040896", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2457436, "fiftyTwoWeekLowChange": 5.6200004, "fiftyTwoWeekLowChangePercent": 0.9525424, "fiftyTwoWeekRange": "5.9 - 27.0", "fiftyTwoWeekHighChange": -15.48, "fiftyTwoWeekHighChangePercent": -0.5733333, "fiftyTwoWeekChangePercent": -56.182903, "earningsTimestamp": 1762349400, "earningsTimestampStart": 1762349400, "earningsTimestampEnd": 1762349400, "earningsCallTimestampStart": 1762347600, "earningsCallTimestampEnd": 1762347600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.81, "epsForward": -4.66, "epsCurrentYear": -0.724, "priceEpsCurrentYear": -15.911603, "fiftyDayAverageChange": 2.103201, "fiftyDayAverageChangePercent": 0.22334562, "twoHundredDayAverageChange": 2.3766508, "twoHundredDayAverageChangePercent": 0.2599322, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "displayName": "Arvinas", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]